Ranking Alexa Global: # 2,453,859
The main IP address: 109.228.14.72,Your server United Kingdom,Gloucester ISP:Fast Hosts Ltd TLD:com CountryCode:GB
The description :welcome to allergy therapeutics, a european-based pharmaceutical company dedicated to continued allergy prevention....
This report updates in 15-Jun-2018
Created Date: | 1998-06-23 |
Changed Date: | 2017-06-15 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host allergytherapeutics.com. Currently, hosted in United Kingdom and its service provider is Fast Hosts Ltd .
Latitude: | 51.86568069458 |
Longitude: | -2.2430999279022 |
Country: | United Kingdom (GB) |
City: | Gloucester |
Region: | England |
ISP: | Fast Hosts Ltd |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called containing the details of what the browser wants and will accept back from the web server.
Content-Length: | 81823 |
Expires: | -1 |
Pragma: | no-cache |
Cache-Control: | no-cache, no-store |
Date: | Thu, 14 Jun 2018 20:52:12 GMT |
Content-Type: | text/html; charset=utf-8 |
soa: | ns.hosteurope.com. hostmaster.allergytherapeutics.com. 2012060101 86400 3600 1209600 14400 |
txt: | "MS=ms75411758" " v=spf1 mx a:emailantidote.com ip4:80.169.171.101 ip4:89.167.219.0/24 ip4:80.169.59.0/24 v=spf1 include:spf.messagelabs.com ~all" |
ns: | ns.hosteurope.com. ns2.hosteurope.com. |
ipv4: | IP:109.228.14.72 ASN:8560 OWNER:ONEANDONE-AS Brauerstrasse 48, DE Country:GB |
mx: | MX preference = 10, mail exchanger = cluster4.eu.messagelabs.com. MX preference = 20, mail exchanger = cluster4a.eu.messagelabs.com. |
careers contact us log in facebook twitter linkedin about us mission and vision our markets how we create value our science transforming lives delivering convenience specialist expertise allergy vaccines adjuvant systems research and development product development class-leading immunotherapies publications and posters healthcare professionals our products pollinex ® trees pollinex ® grasses + rye skin prick testing diagnostic products uk specials manufacturing service investor relations at a glance financial performance share price information share price charting historic share price download financial indicators financial calendar annual reports shareholder information registrar details major shareholders general meetings electronic communications corporate governance the board corporate documents corporate responsibility internal control advisers analysts and broker forecasts lse regulatory news email alerts aim rule 26 financial presentations careers positions available how to apply contact us how to find us adverse event reporting uk sales contacts corporate details log in × this resource is exclusively available to uk healthcare professionals i hereby confirm that i am a healthcare professional practising in the uk. i accept 's cookies and privacy policy & terms and conditions . decline hcp please check all boxes. specialist expertise we've developed adjuvant technologies aimed to make treatment more efficient than ever more information transforming lives we believe treating the cause, rather than symptoms, achieves transformational outcomes for patients more information print page save page more from delivering convenience we're developing life-changing, convenient allergy treatments. more information our science we're exploring new concepts with our adjuvant technologies including infectious disease and cancer. learn more financial performance read a summary of our latest financial information. more information © 2018 glossary cookies terms and conditions sitemap privacy gender pay gap about us mission and vision how we create value our science transforming lives delivering convenience specialist expertise research and development healthcare professionals our products pollinex ® trees pollinex ® grasses + rye skin prick testing diagnostic products uk specials manufacturing service investor relations financial performance share price information financial indicators financial calendar annual reports --
https://www.allergytherapeutics.com///about-us/our-markets/
https://www.allergytherapeutics.com///login
https://www.allergytherapeutics.com///about-us/how-we-create-value/
https://www.allergytherapeutics.com///gender-pay-gap/
https://www.allergytherapeutics.com///investor-relations/financial-calendar/
https://www.allergytherapeutics.com///contact-us/
https://www.allergytherapeutics.com///investor-relations/analysts-and-broker-forecasts/
https://www.allergytherapeutics.com///contact-us/how-to-find-us/
https://www.allergytherapeutics.com///cookies/
https://www.allergytherapeutics.com///investor-relations/annual-reports/
https://www.allergytherapeutics.com///privacy/
https://www.allergytherapeutics.com///healthcare-professionals/pollinex-trees/
https://www.allergytherapeutics.com///investor-relations/financial-indicators/
https://www.allergytherapeutics.com///healthcare-professionals/pollinex-grasses-plus-rye/
https://www.allergytherapeutics.com///healthcare-professionals/our-products/
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: ALLERGYTHERAPEUTICS.COM
Registry Domain ID: 1816873_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.123-reg.co.uk
Registrar URL: http://www.meshdigital.com
Updated Date: 2017-06-15T05:44:20Z
Creation Date: 1998-06-23T04:00:00Z
Registry Expiry Date: 2022-06-22T04:00:00Z
Registrar: 123-Reg Limited
Registrar IANA ID: 1515
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS.123-REG.CO.UK
Name Server: NS2.123-REG.CO.UK
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-10-01T07:11:42Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR 123-Reg Limited
SERVERS
SERVER com.whois-servers.net
ARGS domain =allergytherapeutics.com
PORT 43
TYPE domain
DOMAIN
NAME allergytherapeutics.com
CHANGED 2017-06-15
CREATED 1998-06-23
STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
NSERVER
NS.123-REG.CO.UK 212.67.202.2
NS2.123-REG.CO.UK 62.138.132.21
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .